Terms: = Colorectal cancer AND SFRP4, Q6FHJ7, 6424, ENSG00000106483, frpHE, MGC26498, FRPHE, FRP-4
21 results:
1. Characterization of Wnt signaling pathway under treatment of Lactobacillus acidophilus postbiotic in colorectal cancer using an integrated in silico and in vitro analysis.
Erfanian N; Nasseri S; Miraki Feriz A; Safarpour H; Namaei MH
Sci Rep; 2023 Dec; 13(1):22988. PubMed ID: 38151510
[TBL] [Abstract] [Full Text] [Related]
2. Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP.
Xie Y; Wang F; Yu J; Zhang J; Liu Y; Li M; Qi J
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617573
[TBL] [Abstract] [Full Text] [Related]
3. Toward colorectal cancer Biomarkers: The Role of Genetic Variation, Wnt Pathway, and Long Noncoding RNAs.
Abdel-Motaleb AI; Azzazy HM; Moustafa A
OMICS; 2021 May; 25(5):302-312. PubMed ID: 33891491
[TBL] [Abstract] [Full Text] [Related]
4. [Expression of secreted frizzled-related protein 4 in DNA mismatch repair-deficient and mismatch repair-proficient colorectal cancers].
Chen K; Liang H; Peng J; Zheng Y
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1300-1305. PubMed ID: 30514676
[TBL] [Abstract] [Full Text] [Related]
5. Validation of epigenetic markers to identify colitis associated cancer: Results of module 1 of the ENDCAP-C study.
Beggs AD; Mehta S; Deeks JJ; James JD; Caldwell GM; Dilworth MP; Stockton JD; Blakeway D; Pestinger V; Vince A; Taniere P; Iqbal T; Magill L; Matthews G; Morton DG;
EBioMedicine; 2019 Jan; 39():265-271. PubMed ID: 30473377
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Significance of Tumor Deposits in Stage III Colon cancer.
Mirkin KA; Kulaylat AS; Hollenbeak CS; Messaris E
Ann Surg Oncol; 2018 Oct; 25(11):3179-3184. PubMed ID: 30083832
[TBL] [Abstract] [Full Text] [Related]
7. Secreted frizzled-related protein 4 and its implications in cancer and apoptosis.
Pohl S; Scott R; Arfuso F; Perumal V; Dharmarajan A
Tumour Biol; 2015 Jan; 36(1):143-52. PubMed ID: 25501511
[TBL] [Abstract] [Full Text] [Related]
8. Promoter methylation analysis of WNT/β-catenin pathway regulators and its association with expression of DNMT1 enzyme in colorectal cancer.
Samaei NM; Yazdani Y; Alizadeh-Navaei R; Azadeh H; Farazmandfar T
J Biomed Sci; 2014 Aug; 21(1):73. PubMed ID: 25107489
[TBL] [Abstract] [Full Text] [Related]
9. Distinct WNT/β-catenin signaling activation in the serrated neoplasia pathway and the adenoma-carcinoma sequence of the colorectum.
Murakami T; Mitomi H; Saito T; Takahashi M; Sakamoto N; Fukui N; Yao T; Watanabe S
Mod Pathol; 2015 Jan; 28(1):146-58. PubMed ID: 24925057
[TBL] [Abstract] [Full Text] [Related]
10. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.
Kamposioras K; Konstantara A; Kotoula V; Lakis S; Kouvatseas G; Akriviadis E; Vrettou E; Dionysopoulos D; Krikelis D; Papadopoulou K; Charalambous E; Chrisafi S; Konstantaras C; Fountzilas G
Anticancer Res; 2013 Oct; 33(10):4573-84. PubMed ID: 24123033
[TBL] [Abstract] [Full Text] [Related]
11. Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence.
Páez D; Gerger A; Zhang W; Yang D; Labonte MJ; Benhanim L; Kahn M; Lenz F; Lenz C; Ning Y; Wakatsuki T; Loupakis F; Lenz HJ
Pharmacogenomics J; 2014 Apr; 14(2):142-50. PubMed ID: 23817222
[TBL] [Abstract] [Full Text] [Related]
12. Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer.
Frank B; Hoffmeister M; Klopp N; Illig T; Chang-Claude J; Brenner H
Carcinogenesis; 2010 Aug; 31(8):1381-6. PubMed ID: 20403915
[TBL] [Abstract] [Full Text] [Related]
13. sfrp4 was overexpressed in colorectal carcinoma.
Huang D; Yu B; Deng Y; Sheng W; Peng Z; Qin W; Du X
J Cancer Res Clin Oncol; 2010 Mar; 136(3):395-401. PubMed ID: 19730886
[TBL] [Abstract] [Full Text] [Related]
14. Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia.
Dhir M; Montgomery EA; Glöckner SC; Schuebel KE; Hooker CM; Herman JG; Baylin SB; Gearhart SL; Ahuja N
J Gastrointest Surg; 2008 Oct; 12(10):1745-53. PubMed ID: 18716850
[TBL] [Abstract] [Full Text] [Related]
15. Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa.
Belshaw NJ; Elliott GO; Foxall RJ; Dainty JR; Pal N; Coupe A; Garg D; Bradburn DM; Mathers JC; Johnson IT
Br J Cancer; 2008 Jul; 99(1):136-42. PubMed ID: 18542073
[TBL] [Abstract] [Full Text] [Related]
16. Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing.
Linhart HG; Lin H; Yamada Y; Moran E; Steine EJ; Gokhale S; Lo G; Cantu E; Ehrich M; He T; Meissner A; Jaenisch R
Genes Dev; 2007 Dec; 21(23):3110-22. PubMed ID: 18056424
[TBL] [Abstract] [Full Text] [Related]
17. Expression of sfrp-4 and beta-catenin in human colorectal carcinoma.
Feng Han Q; Zhao W; Bentel J; Shearwood AM; Zeps N; Joseph D; Iacopetta B; Dharmarajan A
Cancer Lett; 2006 Jan; 231(1):129-37. PubMed ID: 16356838
[TBL] [Abstract] [Full Text] [Related]
18. WNT antagonist, SFRP1, is Hedgehog signaling target.
Katoh Y; Katoh M
Int J Mol Med; 2006 Jan; 17(1):171-5. PubMed ID: 16328026
[TBL] [Abstract] [Full Text] [Related]
19. Comparative genomics on SFRP2 orthologs.
Katoh M; Katoh M
Oncol Rep; 2005 Sep; 14(3):783-7. PubMed ID: 16077992
[TBL] [Abstract] [Full Text] [Related]
20. Comparative genomics on SFRP1 orthologs.
Katoh Y; Katoh M
Int J Oncol; 2005 Sep; 27(3):861-5. PubMed ID: 16077939
[TBL] [Abstract] [Full Text] [Related]
[Next]
